13
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T77554 | GSK-3 Inhibitor 5 | 4-Cyanophenacyl bromide | GSK-3 |
GSK-3 Inhibitor 5 (4-Cyanophenacyl bromide) is a ketone derivative that is used as an intermediate in pharmaceuticals and organic synthesis, and inhibits glycogen synthase kinase 3 (GSK-3). | |||
T8605 | GS87 | 4-[5-[[(3-Phenyl-1,2,4-oxadiazol-5-yl)methyl]thio]-1,3,4-oxadiazol-2-yl]pyridine | GSK-3 |
GS87 is a highly specific inhibitor of GSK3 (glycogen synthase kinase 3) that induces extensive differentiation of AML cells. | |||
T7361 | Verucerfont | NBI77860,GSK561679 | CRFR |
Verucerfont (NBI77860) is an antagonist of corticotropin-releasing factor receptor 1 (CRF1) . | |||
T2277 | Losmapimod | GSK-AHAB,GW856553X,GW856553,SB856553 | p38 MAPK , Autophagy |
Losmapimod (GSK-AHAB) (GW856553X; SB856553; GSK-AHAB) is a specific, potent, and orally active p38 MAPK inhibitor (pKi: 8.1/7.6 for p38α/β). | |||
T2240 | GSK2578215A | Mitophagy , LRRK2 , Autophagy | |
GSK2578215A is a potent and selective LRRK2 kinase inhibitor. | |||
T10172 | 5-Iodo-indirubin-3'-monoxime | GSK-3 , CDK | |
5-Iodo-indirubin-3'-monoxime is a potent GSK-3β, CDK5/P25 and CDK1/cyclin B inhibitor, competing with ATP for binding to the catalytic site of the kinase (IC50s: 9, 20 and 25 nM). | |||
T3067 | Tideglusib | NP-12,NP031112 | GSK-3 |
Tideglusib (NP031112), a non-ATP competitive inhibitor of glycogen synthase kinase 3 (GSK-3), is with anti-inflammatory and neuroprotective activities. | |||
T7473 | 5-Bromoindole | GSK-3 | |
5-bromoindole is a potential inhibitor of glycogen synthase kinase 3 (GSK-3)and an important pharmaceutical chemical intermediate | |||
T1917 | GSK 3 Inhibitor IX | BIO,GSK 3 IX,6-BIO,6-Bromoindirubin-3'-oxime,MLS 2052,6-bromoindirubin-3-oxime | Apoptosis , GSK-3 , Tyrosine Kinases , CDK |
GSK 3 Inhibitor IX (6-BIO) is a selective reversible, ATP-competitive inhibitor of GSK-3α/β and CDK1-cyclinB complex. It inhibits (GSK-3α/β)/CDK1/CDK5 activity with IC50 values of 5 nM/320 nM/83 nM, respectively. | |||
T1957 | AZD2858 | GSK-3 | |
AZD2858 is a selective GSK-3 inhibitor, inhibiting tau phosphorylation at the S396 site and activating Wnt signaling pathway. | |||
T2378 | RGB-286638 free base | GSK-3 , MEK , JAK , CDK | |
RGB-286638 free base is a novel CDK inhibitor with IC50s of 1 nM/2 nM/3 nM/4 nM/5 nM for cyclin T1-CDK9/cyclin B1-CDK1/cyclin E-CDK2/cyclin D1-CDK4/cyclin E-CDK3/p35-CDK5 respectively; less potent against cyclin H-CDK7 a... | |||
T11652 | Indirubin-3'-monoxime-5-sulphonic acid | Others | |
Indirubin-3'-monoxime-5-sulphonic acid is a potent and selective inhibitor of GSK-3β, CDK5, and CDK1 with IC50s of 80nM,5 nM, and 7 nM, respectively. | |||
T73196 | RGB-286638 | ||
RGB-286638 is a multi-target CDK inhibitor that effectively hampers the kinase activity of a range of cyclin-CDK complexes, including cyclin T1-CDK9 (IC50 = 1 nM), cyclin B1-CDK1 (IC50 = 2 nM), cyclin E-CDK2 (IC50 = 3 nM... |